Atlas Trials

Safety and Efficacy of HRS-9190 Compared to Cisatracurium for Continuous Intravenous Infusion in Adults

Clinical trial NCT07446309 · RECRUITING

Trial details

NCT number
NCT07446309
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Neuromuscular Blockade
Start date
2026-04-10
Primary completion
2026-07-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.